Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Importance: Deferred cord clamping (DCC) with high oxygen may reduce early hypoxia in preterm newborns. However, the safety and efficacy of this procedure has never been studied.

Objective: To determine whether providing 100% oxygen by face mask during the window of DCC in preterm infants reduces hypoxemia compared with 30% oxygen without hyperoxemia due to the continued mixing with umbilical venous blood.

Design, Setting, And Participants: This double-blinded randomized clinical trial took place from November 2021 to October 2024 at 2 universities and 1 private medical center in California. Participants included 140 preterm infants (born at 22 to 28 weeks' gestation). These data were analyzed from November 2024 to May 2025.

Interventions: During DCC, infants received continuous positive airway pressure or positive pressure ventilation via face mask and were randomized to either 30% (low oxygen group) or 100% (high oxygen group) using a concealed blender. After the umbilical cord was clamped and cut, each infant was resuscitated per contemporary guidelines (30% oxygen and titration based on saturation of peripheral oxygen).

Main Outcome: The primary outcome was the number of infants who achieve peripheral oxygen saturations of 80% by 5 minutes of life.

Results: There were 140 infants randomized (mean gestational age, 26 weeks; 69 female [49%] and 71 male [51%]). In the low oxygen group, 28 of 72 infants (39%) achieved a peripheral oxygen saturation of 80% by 5 minutes compared with 47 of 68 infants (69%) in the high oxygen group (adjusted odds ratio, 3.74; 95% CI, 1.80-7.79; P < .001). The absolute risk difference between the 2 groups was 0.3 (95% CI, 0.26-0.35), indicating that the high oxygen group had a 30% lower risk of experiencing hypoxemia 5 minutes after birth. Maximum median fraction of inspired oxygen during resuscitation after DCC, umbilical arterial partial pressure of oxygen in arterial blood, severe intraventricular hemorrhage, and death before 40 weeks' postmenstrual age were not different between groups.

Conclusion And Relevance: In this study, 100% oxygen during DCC reduced early hypoxemia without increased morbidity. A large randomized clinical trial is needed to determine if 100% oxygen during DCC improves survival and reduces longer-term morbidities in extremely preterm infants.

Trial Registration: ClinicalTrials.gov Identifier: NCT04413097.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12281397PMC
http://dx.doi.org/10.1001/jamapediatrics.2025.2128DOI Listing

Publication Analysis

Top Keywords

high oxygen
16
oxygen group
16
preterm infants
12
oxygen
11
deferred cord
8
cord clamping
8
infants
8
infants randomized
8
randomized clinical
8
clinical trial
8

Similar Publications

Background: Several studies have suggested that adult human dermal fibroblasts (HDFa) may be a potential alternative source to mesenchymal stem cells for cell therapies. This study aims to characterize HDFa, adipose-derived stem cells (ADMSCs) and dental pulp stem cells (DPSCs) to investigate their proliferation, differentiation potential, mitochondrial respiration, and metabolomic profile. We identified molecules and characteristics that would differentiate MSCs from different sources or confirm their uniformity.

View Article and Find Full Text PDF

This review delivers a focused and critical evaluation of recent progress in the green synthesis of carbon quantum dots (CQDs), with particular attention to state-of-the-art approaches utilizing renewable biomass as precursors. The main objective is to systematically examine innovative, environmentally friendly methods and clarify their direct influence on the core properties and photocatalytic performance of CQDs. The novelty of this review stems from its comprehensive comparison of green synthetic pathways, revealing how specific processes determine key structural, optical, and electronic attributes of the resulting CQDs.

View Article and Find Full Text PDF

ACP-105 (CAS: 1048998-11-3) is a novel non-steroidal selective androgen receptor modulator (SARM), increasingly detected in anti-doping analyses, yet lacking a comprehensive ADME profile. This study provides the first integrative in silico characterization of ACP-105's ADME properties using seven independent methods (ADMETlab 3.0, ADMET Predictor 12.

View Article and Find Full Text PDF

Alteration in hippocampal mitochondria ultrastructure and cholesterol accumulation linked to mitochondrial dysfunction in the valproic acid rat model of autism spectrum disorders.

Psychopharmacology (Berl)

September 2025

Instituto de Biología Celular y Neurociencias "Prof. De Robertis" (IBCN), CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.

Rationale: Autism spectrum disorders (ASD) are a group of neurodevelopmental and multifactorial conditions with cognitive manifestations. The valproic acid (VPA) rat model is a well-validated model that successfully reproduces the behavioral and neuroanatomical alterations of ASD. Previous studies found atypical brain connectivity and metabolic patterns in VPA animals: local glucose hypermetabolism in the prefrontal cortex, with no metabolic changes in the hippocampus.

View Article and Find Full Text PDF

The surfaces of 1D layered lepidocrocite-structured titanates (1DLs) are negatively charged due to an oxygen-to-titanium atomic ratio >2. This, and their layered structure, allow for facile ion exchange and high colloidal stability, demonstrated by ζ-potentials of ≈ -85 mV at their unadjusted pH of ≈10.4.

View Article and Find Full Text PDF